NEUROLOGIC SIGNS AND SYMPTOMS FREQUENTLY MANIFEST IN ACUTE HIV INFECTION by Kamtchum-Tatuene, Joseph et al.
7. Cruccu G, Finnerup NB, Jensen TS, et al. Trigeminal neu-
ralgia: new classification and diagnostic grading for practice
and research. Neurology Epub 2016 Jun 15.
8. Antonini G, Di Pasquale A, Cruccu G, et al. Magnetic
resonance imaging contribution for diagnosing symptom-
atic neurovascular contact in classical trigeminal neuralgia:
a blinded case-control study and meta-analysis. Pain 2014;
155:1464–1471.
9. Truini A, Garcia-Larrea L, Cruccu G. Reappraising neuro-
pathic pain in humans: how symptoms help disclose mech-
anisms. Nat Rev Neurol 2013;9:572–582.
NEUROLOGIC SIGNS AND SYMPTOMS
FREQUENTLY MANIFEST IN ACUTE HIV
INFECTION
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Sulaiman, Liverpool, UK; Alain Lekoubou,
Charleston, SC: According to the article by Hell-
muth et al.,1 the prevalence of neurologic signs and
symptoms in acute HIV infection is 53%. Although
not apparent in the title, only mild neurologic findings
were reported in otherwise healthy homosexual men
infected with HIV-1 subtype CRF01-AE. It is possible
that cases of acute HIV infection that manifest as
neurologic emergencies were missed, such as stroke,
Guillain-Barré syndrome, meningitis, encephalitis,
and myelitis.2,3 Moreover, other HIV-1 subtypes (nota-
bly subtype D) are more virulent and might induce
more neurologic symptoms.4 Therefore, the real prev-
alence and spectrum of neurologic involvement in
acute HIV infection were probably underestimated.
When also considering the results presented by
Hellmuth et al., it appears that neurologists are
expected to be involved in the management of at least
1 out of 2 patients acutely infected with HIV. Conse-
quently, neurologists have a key responsibility in
ensuring timely diagnosis and treatment of HIV
infection to help improve patients’ short- and long-
term outcomes. Being on the front line in the war
against HIV, neurologists should have a low threshold
for screening patients for HIV infection regardless of
severity of symptoms and risk factors.5
Author Response: Joanna Hellmuth, Victor
Valcour, San Francisco; Serena Spudich, New
Haven, CT: We thank Kamtchum-Tatuene et al.
for the comments and interest in our article.1 We
agree it is critical to engage neurologists in HIV test-
ing for new, unexplained neurologic findings, even if
mild. Along with the standard HIV antibody assay,
plasma HIV RNA must be ordered to detect acute
HIV. Diagnosing acute HIV is an opportunity to
rapidly initiate treatment, to decrease HIV transmis-
sion during a highly infectious stage,6 to reduce the
size of a patient’s latent HIV reservoir,7 and possibly
to decrease the chance of developing fulminant neu-
rologic manifestations.
Our study participants were identified through
voluntary HIV testing, which happened to occur
within days or weeks of infection. It is conceivable
that this methodology may underestimate the preva-
lence or severity of neurologic issues in acute HIV,
as individuals with more pronounced neurologic dis-
orders may have first presented to other clinical pro-
viders. In addition, all participants rapidly initiated
combination antiretroviral therapy, which may
have minimized development of neurologic issues
during the study.
The neurologic findings we identified in acute
HIV were often mild and may not have prompted
neurologic referral and evaluation. Thus, our study
argues for greater vigilance of all providers regarding
neurologic presentations of acute HIV.1
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